Loading…

Circulating Sestrin Levels Are Increased in Hypertension Patients

Background. Sestrins (Sesns), a group of oxidative stress-related proteins, have been reported to be involved in various cardiovascular diseases, including aortic dissection and chronic heart failure. This study is aimed at investigating the level of circulating Sesn1, Sesn2, and Sesn3 in hypertensi...

Full description

Saved in:
Bibliographic Details
Published in:Disease markers 2020, Vol.2020 (2020), p.1-8
Main Authors: Lin, Ying-zhong, Liu, Ling, Shi, Ying, Zeng, Tao, Shi, Lei, Yang, Zicong, Fang, Cao, Liu, Hongtao
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c499t-286c4e1913d9d6fa23824a4260fb87e97513bc0c434b4798ce7cbd702c1f1fa03
cites cdi_FETCH-LOGICAL-c499t-286c4e1913d9d6fa23824a4260fb87e97513bc0c434b4798ce7cbd702c1f1fa03
container_end_page 8
container_issue 2020
container_start_page 1
container_title Disease markers
container_volume 2020
creator Lin, Ying-zhong
Liu, Ling
Shi, Ying
Zeng, Tao
Shi, Lei
Yang, Zicong
Fang, Cao
Liu, Hongtao
description Background. Sestrins (Sesns), a group of oxidative stress-related proteins, have been reported to be involved in various cardiovascular diseases, including aortic dissection and chronic heart failure. This study is aimed at investigating the level of circulating Sesn1, Sesn2, and Sesn3 in hypertension patients. Methods. Plasma levels of Sesn1, Sesn2, and Sesn3 in 400 hypertensive patients and 100 normotensive subjects were detected using enzyme-linked immunosorbent assay (ELISA) kits. The hypertension patients were divided into groups with grade I (n=140), grade II (n=180), and grade III (n=80) hypertension. Results. Compared with the normotensive subjects, Sesn1, Sesn2, and Sesn3 levels were increased in patients with hypertension, with a gradual increase between the groups with grade I, grade II, and grade III hypertension. Elevated Sesn1, Sesn2, and Sesn3 levels were positively correlated with both the systolic blood pressure (SBP) and diastolic blood pressure (DBP). Moreover, Sesn1, Sesn2, and Sesn3 levels were elevated in patients with dipper hypertension and further increased in patients with nondipper hypertension. In addition, smokers, as well as patients with higher levels of angiotensin II (Ang II) and carotid atherosclerotic plaque (CAP), exhibited increased Sesn1, Sesn2, and Sesn3 levels when compared with patients without these clinical characteristics. Furthermore, plasma levels of Sesn1, Sesn2, and Sesn3 were negatively correlated with the presence of CAP. Conclusions. Circulating Sesn levels are increased in patients with hypertension and may be a target for the prevention and treatment of clinical hypertension.
doi_str_mv 10.1155/2020/3787295
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7306853</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A632853497</galeid><sourcerecordid>A632853497</sourcerecordid><originalsourceid>FETCH-LOGICAL-c499t-286c4e1913d9d6fa23824a4260fb87e97513bc0c434b4798ce7cbd702c1f1fa03</originalsourceid><addsrcrecordid>eNqNkd1LHDEUxUOx1NX61ucy4EvBjub740VYlrYKCxVan0Mmc2eNzGbWZMbif98su9XWpz6EC8nvnpPDQegDweeECHFBMcUXTGlFjXiDZkQrUWvJ8AGaYap0jSnHh-go53uMCTXcvEOHjEoqBSczNF-E5KfejSGuqh-QxxRitYRH6HM1T1BdR5_AZWircn_1tIE0QsxhiNVN2YE45vfobef6DCf7eYxuv375ubiql9-_XS_my9pzY8aaauk5EENYa1rZOco05Y5TibtGKzBKENZ47DnjDVdGe1C-aRWmnnSkc5gdo8ud7mZq1tD64p1cbzcprF16soML9t-XGO7sani0imGpBSsCn_YCaXiYSlS7DtlD37sIw5Qt5RTLcrgo6Okr9H6YUizxCkUEJUJq80KtXA82xG4ovn4raueS0eLJjSrU5x3l05Bzgu75ywTbbYN226DdN1jwj3_HfIb_VFaAsx1wF2LrfoX_lIPCQOdeaCJKA4r9Bo7rqzc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2415215689</pqid></control><display><type>article</type><title>Circulating Sestrin Levels Are Increased in Hypertension Patients</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><creator>Lin, Ying-zhong ; Liu, Ling ; Shi, Ying ; Zeng, Tao ; Shi, Lei ; Yang, Zicong ; Fang, Cao ; Liu, Hongtao</creator><contributor>Dugue, Benoit ; Benoit Dugue</contributor><creatorcontrib>Lin, Ying-zhong ; Liu, Ling ; Shi, Ying ; Zeng, Tao ; Shi, Lei ; Yang, Zicong ; Fang, Cao ; Liu, Hongtao ; Dugue, Benoit ; Benoit Dugue</creatorcontrib><description>Background. Sestrins (Sesns), a group of oxidative stress-related proteins, have been reported to be involved in various cardiovascular diseases, including aortic dissection and chronic heart failure. This study is aimed at investigating the level of circulating Sesn1, Sesn2, and Sesn3 in hypertension patients. Methods. Plasma levels of Sesn1, Sesn2, and Sesn3 in 400 hypertensive patients and 100 normotensive subjects were detected using enzyme-linked immunosorbent assay (ELISA) kits. The hypertension patients were divided into groups with grade I (n=140), grade II (n=180), and grade III (n=80) hypertension. Results. Compared with the normotensive subjects, Sesn1, Sesn2, and Sesn3 levels were increased in patients with hypertension, with a gradual increase between the groups with grade I, grade II, and grade III hypertension. Elevated Sesn1, Sesn2, and Sesn3 levels were positively correlated with both the systolic blood pressure (SBP) and diastolic blood pressure (DBP). Moreover, Sesn1, Sesn2, and Sesn3 levels were elevated in patients with dipper hypertension and further increased in patients with nondipper hypertension. In addition, smokers, as well as patients with higher levels of angiotensin II (Ang II) and carotid atherosclerotic plaque (CAP), exhibited increased Sesn1, Sesn2, and Sesn3 levels when compared with patients without these clinical characteristics. Furthermore, plasma levels of Sesn1, Sesn2, and Sesn3 were negatively correlated with the presence of CAP. Conclusions. Circulating Sesn levels are increased in patients with hypertension and may be a target for the prevention and treatment of clinical hypertension.</description><identifier>ISSN: 0278-0240</identifier><identifier>EISSN: 1875-8630</identifier><identifier>DOI: 10.1155/2020/3787295</identifier><identifier>PMID: 32626541</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Adult ; Age ; Angiotensin ; Angiotensin II ; Aorta ; Arteriosclerosis ; Atherosclerosis ; Autophagy ; Biomarkers - blood ; Blood pressure ; Body mass index ; Cardiovascular disease ; Cardiovascular diseases ; Case-Control Studies ; Cholesterol ; Comparative analysis ; Congestive heart failure ; Creatinine ; Enzyme-linked immunosorbent assay ; Enzymes ; Female ; Heart failure ; Heart rate ; Heat-Shock Proteins - blood ; Hemoglobin ; Homocysteine ; Humans ; Hypertension ; Hypertension - blood ; Levels ; Lipoproteins ; Male ; Middle Aged ; Nuclear Proteins - blood ; Oxidative stress ; Patients ; Plasma ; Plasma levels ; Regression analysis ; Risk Factors ; Severity of Illness Index ; Studies ; Triglycerides ; Up-Regulation</subject><ispartof>Disease markers, 2020, Vol.2020 (2020), p.1-8</ispartof><rights>Copyright © 2020 Cao Fang et al.</rights><rights>COPYRIGHT 2020 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2020 Cao Fang et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2020 Cao Fang et al. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c499t-286c4e1913d9d6fa23824a4260fb87e97513bc0c434b4798ce7cbd702c1f1fa03</citedby><cites>FETCH-LOGICAL-c499t-286c4e1913d9d6fa23824a4260fb87e97513bc0c434b4798ce7cbd702c1f1fa03</cites><orcidid>0000-0003-4424-0340 ; 0000-0003-3790-6159 ; 0000-0001-9822-1423</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,4010,27904,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32626541$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Dugue, Benoit</contributor><contributor>Benoit Dugue</contributor><creatorcontrib>Lin, Ying-zhong</creatorcontrib><creatorcontrib>Liu, Ling</creatorcontrib><creatorcontrib>Shi, Ying</creatorcontrib><creatorcontrib>Zeng, Tao</creatorcontrib><creatorcontrib>Shi, Lei</creatorcontrib><creatorcontrib>Yang, Zicong</creatorcontrib><creatorcontrib>Fang, Cao</creatorcontrib><creatorcontrib>Liu, Hongtao</creatorcontrib><title>Circulating Sestrin Levels Are Increased in Hypertension Patients</title><title>Disease markers</title><addtitle>Dis Markers</addtitle><description>Background. Sestrins (Sesns), a group of oxidative stress-related proteins, have been reported to be involved in various cardiovascular diseases, including aortic dissection and chronic heart failure. This study is aimed at investigating the level of circulating Sesn1, Sesn2, and Sesn3 in hypertension patients. Methods. Plasma levels of Sesn1, Sesn2, and Sesn3 in 400 hypertensive patients and 100 normotensive subjects were detected using enzyme-linked immunosorbent assay (ELISA) kits. The hypertension patients were divided into groups with grade I (n=140), grade II (n=180), and grade III (n=80) hypertension. Results. Compared with the normotensive subjects, Sesn1, Sesn2, and Sesn3 levels were increased in patients with hypertension, with a gradual increase between the groups with grade I, grade II, and grade III hypertension. Elevated Sesn1, Sesn2, and Sesn3 levels were positively correlated with both the systolic blood pressure (SBP) and diastolic blood pressure (DBP). Moreover, Sesn1, Sesn2, and Sesn3 levels were elevated in patients with dipper hypertension and further increased in patients with nondipper hypertension. In addition, smokers, as well as patients with higher levels of angiotensin II (Ang II) and carotid atherosclerotic plaque (CAP), exhibited increased Sesn1, Sesn2, and Sesn3 levels when compared with patients without these clinical characteristics. Furthermore, plasma levels of Sesn1, Sesn2, and Sesn3 were negatively correlated with the presence of CAP. Conclusions. Circulating Sesn levels are increased in patients with hypertension and may be a target for the prevention and treatment of clinical hypertension.</description><subject>Adult</subject><subject>Age</subject><subject>Angiotensin</subject><subject>Angiotensin II</subject><subject>Aorta</subject><subject>Arteriosclerosis</subject><subject>Atherosclerosis</subject><subject>Autophagy</subject><subject>Biomarkers - blood</subject><subject>Blood pressure</subject><subject>Body mass index</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Case-Control Studies</subject><subject>Cholesterol</subject><subject>Comparative analysis</subject><subject>Congestive heart failure</subject><subject>Creatinine</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Enzymes</subject><subject>Female</subject><subject>Heart failure</subject><subject>Heart rate</subject><subject>Heat-Shock Proteins - blood</subject><subject>Hemoglobin</subject><subject>Homocysteine</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - blood</subject><subject>Levels</subject><subject>Lipoproteins</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nuclear Proteins - blood</subject><subject>Oxidative stress</subject><subject>Patients</subject><subject>Plasma</subject><subject>Plasma levels</subject><subject>Regression analysis</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Studies</subject><subject>Triglycerides</subject><subject>Up-Regulation</subject><issn>0278-0240</issn><issn>1875-8630</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqNkd1LHDEUxUOx1NX61ucy4EvBjub740VYlrYKCxVan0Mmc2eNzGbWZMbif98su9XWpz6EC8nvnpPDQegDweeECHFBMcUXTGlFjXiDZkQrUWvJ8AGaYap0jSnHh-go53uMCTXcvEOHjEoqBSczNF-E5KfejSGuqh-QxxRitYRH6HM1T1BdR5_AZWircn_1tIE0QsxhiNVN2YE45vfobef6DCf7eYxuv375ubiql9-_XS_my9pzY8aaauk5EENYa1rZOco05Y5TibtGKzBKENZ47DnjDVdGe1C-aRWmnnSkc5gdo8ud7mZq1tD64p1cbzcprF16soML9t-XGO7sani0imGpBSsCn_YCaXiYSlS7DtlD37sIw5Qt5RTLcrgo6Okr9H6YUizxCkUEJUJq80KtXA82xG4ovn4raueS0eLJjSrU5x3l05Bzgu75ywTbbYN226DdN1jwj3_HfIb_VFaAsx1wF2LrfoX_lIPCQOdeaCJKA4r9Bo7rqzc</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Lin, Ying-zhong</creator><creator>Liu, Ling</creator><creator>Shi, Ying</creator><creator>Zeng, Tao</creator><creator>Shi, Lei</creator><creator>Yang, Zicong</creator><creator>Fang, Cao</creator><creator>Liu, Hongtao</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7TK</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4424-0340</orcidid><orcidid>https://orcid.org/0000-0003-3790-6159</orcidid><orcidid>https://orcid.org/0000-0001-9822-1423</orcidid></search><sort><creationdate>2020</creationdate><title>Circulating Sestrin Levels Are Increased in Hypertension Patients</title><author>Lin, Ying-zhong ; Liu, Ling ; Shi, Ying ; Zeng, Tao ; Shi, Lei ; Yang, Zicong ; Fang, Cao ; Liu, Hongtao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c499t-286c4e1913d9d6fa23824a4260fb87e97513bc0c434b4798ce7cbd702c1f1fa03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Age</topic><topic>Angiotensin</topic><topic>Angiotensin II</topic><topic>Aorta</topic><topic>Arteriosclerosis</topic><topic>Atherosclerosis</topic><topic>Autophagy</topic><topic>Biomarkers - blood</topic><topic>Blood pressure</topic><topic>Body mass index</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Case-Control Studies</topic><topic>Cholesterol</topic><topic>Comparative analysis</topic><topic>Congestive heart failure</topic><topic>Creatinine</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Enzymes</topic><topic>Female</topic><topic>Heart failure</topic><topic>Heart rate</topic><topic>Heat-Shock Proteins - blood</topic><topic>Hemoglobin</topic><topic>Homocysteine</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - blood</topic><topic>Levels</topic><topic>Lipoproteins</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nuclear Proteins - blood</topic><topic>Oxidative stress</topic><topic>Patients</topic><topic>Plasma</topic><topic>Plasma levels</topic><topic>Regression analysis</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Studies</topic><topic>Triglycerides</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lin, Ying-zhong</creatorcontrib><creatorcontrib>Liu, Ling</creatorcontrib><creatorcontrib>Shi, Ying</creatorcontrib><creatorcontrib>Zeng, Tao</creatorcontrib><creatorcontrib>Shi, Lei</creatorcontrib><creatorcontrib>Yang, Zicong</creatorcontrib><creatorcontrib>Fang, Cao</creatorcontrib><creatorcontrib>Liu, Hongtao</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Disease markers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lin, Ying-zhong</au><au>Liu, Ling</au><au>Shi, Ying</au><au>Zeng, Tao</au><au>Shi, Lei</au><au>Yang, Zicong</au><au>Fang, Cao</au><au>Liu, Hongtao</au><au>Dugue, Benoit</au><au>Benoit Dugue</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Circulating Sestrin Levels Are Increased in Hypertension Patients</atitle><jtitle>Disease markers</jtitle><addtitle>Dis Markers</addtitle><date>2020</date><risdate>2020</risdate><volume>2020</volume><issue>2020</issue><spage>1</spage><epage>8</epage><pages>1-8</pages><issn>0278-0240</issn><eissn>1875-8630</eissn><abstract>Background. Sestrins (Sesns), a group of oxidative stress-related proteins, have been reported to be involved in various cardiovascular diseases, including aortic dissection and chronic heart failure. This study is aimed at investigating the level of circulating Sesn1, Sesn2, and Sesn3 in hypertension patients. Methods. Plasma levels of Sesn1, Sesn2, and Sesn3 in 400 hypertensive patients and 100 normotensive subjects were detected using enzyme-linked immunosorbent assay (ELISA) kits. The hypertension patients were divided into groups with grade I (n=140), grade II (n=180), and grade III (n=80) hypertension. Results. Compared with the normotensive subjects, Sesn1, Sesn2, and Sesn3 levels were increased in patients with hypertension, with a gradual increase between the groups with grade I, grade II, and grade III hypertension. Elevated Sesn1, Sesn2, and Sesn3 levels were positively correlated with both the systolic blood pressure (SBP) and diastolic blood pressure (DBP). Moreover, Sesn1, Sesn2, and Sesn3 levels were elevated in patients with dipper hypertension and further increased in patients with nondipper hypertension. In addition, smokers, as well as patients with higher levels of angiotensin II (Ang II) and carotid atherosclerotic plaque (CAP), exhibited increased Sesn1, Sesn2, and Sesn3 levels when compared with patients without these clinical characteristics. Furthermore, plasma levels of Sesn1, Sesn2, and Sesn3 were negatively correlated with the presence of CAP. Conclusions. Circulating Sesn levels are increased in patients with hypertension and may be a target for the prevention and treatment of clinical hypertension.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>32626541</pmid><doi>10.1155/2020/3787295</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-4424-0340</orcidid><orcidid>https://orcid.org/0000-0003-3790-6159</orcidid><orcidid>https://orcid.org/0000-0001-9822-1423</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0278-0240
ispartof Disease markers, 2020, Vol.2020 (2020), p.1-8
issn 0278-0240
1875-8630
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7306853
source Open Access: Wiley-Blackwell Open Access Journals
subjects Adult
Age
Angiotensin
Angiotensin II
Aorta
Arteriosclerosis
Atherosclerosis
Autophagy
Biomarkers - blood
Blood pressure
Body mass index
Cardiovascular disease
Cardiovascular diseases
Case-Control Studies
Cholesterol
Comparative analysis
Congestive heart failure
Creatinine
Enzyme-linked immunosorbent assay
Enzymes
Female
Heart failure
Heart rate
Heat-Shock Proteins - blood
Hemoglobin
Homocysteine
Humans
Hypertension
Hypertension - blood
Levels
Lipoproteins
Male
Middle Aged
Nuclear Proteins - blood
Oxidative stress
Patients
Plasma
Plasma levels
Regression analysis
Risk Factors
Severity of Illness Index
Studies
Triglycerides
Up-Regulation
title Circulating Sestrin Levels Are Increased in Hypertension Patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T05%3A19%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Circulating%20Sestrin%20Levels%20Are%20Increased%20in%20Hypertension%20Patients&rft.jtitle=Disease%20markers&rft.au=Lin,%20Ying-zhong&rft.date=2020&rft.volume=2020&rft.issue=2020&rft.spage=1&rft.epage=8&rft.pages=1-8&rft.issn=0278-0240&rft.eissn=1875-8630&rft_id=info:doi/10.1155/2020/3787295&rft_dat=%3Cgale_pubme%3EA632853497%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c499t-286c4e1913d9d6fa23824a4260fb87e97513bc0c434b4798ce7cbd702c1f1fa03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2415215689&rft_id=info:pmid/32626541&rft_galeid=A632853497&rfr_iscdi=true